48 related articles for article (PubMed ID: 21947124)
21. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
22. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
24. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
26. A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.
Gunn GB; Endres EJ; Parker B; Sormani MP; Sanguineti G
Strahlenther Onkol; 2010 Sep; 186(9):489-95. PubMed ID: 20803186
[TBL] [Abstract][Full Text] [Related]
27. Pattern of failure after helical tomotherapy in head and neck cancer.
Farrag A; Voordeckers M; Tournel K; De Coninck P; Storme G
Strahlenther Onkol; 2010 Sep; 186(9):511-6. PubMed ID: 20803182
[TBL] [Abstract][Full Text] [Related]
28. Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis.
Steinmann D; Cerny B; Karstens JH; Bremer M
Strahlenther Onkol; 2009 Oct; 185(10):682-8. PubMed ID: 19806334
[TBL] [Abstract][Full Text] [Related]
29. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.
Tribius S; Kronemann S; Kilic Y; Schroeder U; Hakim S; Schild SE; Rades D
Strahlenther Onkol; 2009 Oct; 185(10):675-81. PubMed ID: 19806333
[TBL] [Abstract][Full Text] [Related]
30. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
[TBL] [Abstract][Full Text] [Related]
31. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
[TBL] [Abstract][Full Text] [Related]
32. Optimum overall times II: Extended modelling for head and neck radiotherapy.
Fowler JF
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):113-26. PubMed ID: 18155893
[TBL] [Abstract][Full Text] [Related]
33. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
Fowler JF
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA; Harari PM; Giralt J; Azarnia N; Shin DM; Cohen RB; Jones CU; Sur R; Raben D; Jassem J; Ove R; Kies MS; Baselga J; Youssoufian H; Amellal N; Rowinsky EK; Ang KK
N Engl J Med; 2006 Feb; 354(6):567-78. PubMed ID: 16467544
[TBL] [Abstract][Full Text] [Related]
35. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
Terhaard CH; Kal HB; Hordijk GJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
[TBL] [Abstract][Full Text] [Related]
36. The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.
Eriksen JG; Steiniche T; Overgaard J;
Radiother Oncol; 2005 Feb; 74(2):93-100. PubMed ID: 15816106
[TBL] [Abstract][Full Text] [Related]
37. Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations.
Bourhis J; Etessami A; Wilbault P; Lusinchi A; Calais G; Lapeyre M; Pignon JP
Curr Opin Oncol; 2004 May; 16(3):215-9. PubMed ID: 15069315
[TBL] [Abstract][Full Text] [Related]
38. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
Fowler JF; Harari PM; Leborgne F; Leborgne JH
Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
[TBL] [Abstract][Full Text] [Related]
39. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Overgaard J; Hansen HS; Specht L; Overgaard M; Grau C; Andersen E; Bentzen J; Bastholt L; Hansen O; Johansen J; Andersen L; Evensen JF
Lancet; 2003 Sep; 362(9388):933-40. PubMed ID: 14511925
[TBL] [Abstract][Full Text] [Related]
40. Extinction of the weakest.
Denham JW; Kron T
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):807-19. PubMed ID: 11697327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
